Sec. 209. The Department, taking into consideration the recommendations of its Prescription Monitoring Program Advisory Committee, may issue a rule scheduling a substance.

81 words·~1 min read·/il/chapter-720/act-570/209

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

Sec. 209. The Department, taking into consideration the recommendations of its Prescription Monitoring Program Advisory Committee, may issue a rule scheduling a substance in Schedule IV if it finds that:

(1)the substance has a low potential for misuse relative to substances in Schedule III;

(2)the substance has currently accepted medical use in treatment in the United States;

and

(3)misuse of the substance may lead to limited physiological dependence or

psychological dependence relative to the substances in Schedule III.